Lung Cancer Surgery Market by Surgical Devices (Endo Surgical Equipment, Monitoring & Visualizing Systems, Surgical Instruments), Surgical Procedures (Minimally Invasive Surgeries, Thoracotomy) - Global Forecast 2024-2030

Lung Cancer Surgery Market by Surgical Devices (Endo Surgical Equipment, Monitoring & Visualizing Systems, Surgical Instruments), Surgical Procedures (Minimally Invasive Surgeries, Thoracotomy) - Global Forecast 2024-2030


The Lung Cancer Surgery Market size was estimated at USD 5.67 billion in 2023 and expected to reach USD 6.01 billion in 2024, at a CAGR 5.33% to reach USD 8.16 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Lung Cancer Surgery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Lung Cancer Surgery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Lung Cancer Surgery Market, highlighting leading vendors and their innovative profiles. These include Accuray Inc., Ackermann Instrumente GmbH, AngioDynamics Inc., FusionKraft Surgical Instruments, Intuitive Surgical Inc., Johnson & Johnson Services, Inc., KARL STORZ GmbH, Key Surgical LLC, KLS Martin Group, Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Scanlan International Inc., Siemens Healthineers AG, Sontec Instruments Inc., Surgical Holdings, Teleflex Incorporated, TROKAMED GmbH, and Wexler Surgical Inc..

Market Segmentation & Coverage

This research report categorizes the Lung Cancer Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

Surgical Devices

Endo Surgical Equipment

Monitoring & Visualizing Systems
Cameras & Video Support
Endoscopic Trocars with Optical Views

Surgical Instruments
Hand Instruments

Clamps

Cutters

Elevators

Foreceps

Powered Surgical Equipment

Retractors

Rib Shears

Scissors

Staplers

Trocar
Surgical Procedures

Minimally Invasive Surgeries

Thoracotomy
Lobectomy
Pneumenectomy
Segmentectomy
Sleeve Resection
Region

Americas
Argentina
Brazil
Canada
Mexico
United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Lung Cancer Surgery Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Lung Cancer Surgery Market?
3. What are the technology trends and regulatory frameworks in the Lung Cancer Surgery Market?
4. What is the market share of the leading vendors in the Lung Cancer Surgery Market?
5. Which modes and strategic moves are suitable for entering the Lung Cancer Surgery Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Lung Cancer Surgery Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of lung cancer coupled with growing trend of smoking tobacco
5.1.1.2. Increasing emphasis on early diagnosis & treatment of cancers
5.1.1.3. Growing adoption of minimally invasive techniques
5.1.2. Restraints
5.1.2.1. High cost of lung cancer diagnosis & treatments
5.1.3. Opportunities
5.1.3.1. Rising technological advancements in lung cancer treatment
5.1.3.2. Availability of reimbursements policies
5.1.3.3. Rising government support and funding for surgery
5.1.4. Challenges
5.1.4.1. Dearth of skilled oncologists
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Lung Cancer Surgery Market, by Surgical Devices
6.1. Introduction
6.2. Endo Surgical Equipment
6.3. Monitoring & Visualizing Systems
6.4.1. Cameras & Video Support
6.4.2. Endoscopic Trocars with Optical Views
6.4. Surgical Instruments
6.5.1. Hand Instruments
6.5.2.1. Clamps
6.5.2.2. Cutters
6.5.2.3. Elevators
6.5.2.4. Foreceps
6.5.2.5. Powered Surgical Equipment
6.5.2.6. Retractors
6.5.2.7. Rib Shears
6.5.2.8. Scissors
6.5.2.9. Staplers
6.5.2.10. Trocar
7. Lung Cancer Surgery Market, by Surgical Procedures
7.1. Introduction
7.2. Minimally Invasive Surgeries
7.3. Thoracotomy
7.4.1. Lobectomy
7.4.2. Pneumenectomy
7.4.3. Segmentectomy
7.4.4. Sleeve Resection
8. Americas Lung Cancer Surgery Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Lung Cancer Surgery Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Lung Cancer Surgery Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Accuray Inc.
12.1.2. Ackermann Instrumente GmbH
12.1.3. AngioDynamics Inc.
12.1.4. FusionKraft Surgical Instruments
12.1.5. Intuitive Surgical Inc.
12.1.6. Johnson & Johnson Services, Inc.
12.1.7. KARL STORZ GmbH
12.1.8. Key Surgical LLC
12.1.9. KLS Martin Group
12.1.10. Medtronic PLC
12.1.11. Olympus Corporation
12.1.12. Richard Wolf GmbH
12.1.13. Scanlan International Inc.
12.1.14. Siemens Healthineers AG
12.1.15. Sontec Instruments Inc.
12.1.16. Surgical Holdings
12.1.17. Teleflex Incorporated
12.1.18. TROKAMED GmbH
12.1.19. Wexler Surgical Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. LUNG CANCER SURGERY MARKET RESEARCH PROCESS
FIGURE 2. LUNG CANCER SURGERY MARKET SIZE, 2023 VS 2030
FIGURE 3. LUNG CANCER SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. LUNG CANCER SURGERY MARKET DYNAMICS
FIGURE 7. LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2023 VS 2030 (%)
FIGURE 8. LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2023 VS 2030 (%)
FIGURE 10. LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. LUNG CANCER SURGERY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. LUNG CANCER SURGERY MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings